Merck & Co., Inc. (MRK)
145.95
+0.76
(+0.52%)
USD |
NYSE |
Oct 16, 16:00
145.62
-0.33
(-0.23%)
After-Hours: 20:00
Merck Price : 145.95 for Oct. 16, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 146.96 | 147.80 | 145.61 | 145.95 | 11.23M |
| Oct 15, 2026 | 149.70 | 152.34 | 144.91 | 145.19 | 13.87M |
| Oct 14, 2026 | 143.10 | 148.16 | 142.66 | 147.37 | 9.808M |
| Oct 13, 2026 | 145.85 | 145.93 | 141.58 | 141.98 | 8.380M |
| Oct 12, 2026 | 145.75 | 146.36 | 144.64 | 145.45 | 8.019M |
| Oct 09, 2026 | 141.37 | 146.68 | 141.36 | 145.60 | 9.289M |
| Oct 08, 2026 | 141.90 | 142.77 | 138.89 | 142.38 | 8.411M |
| Oct 07, 2026 | 142.02 | 144.14 | 141.49 | 142.79 | 6.354M |
| Oct 06, 2026 | 140.13 | 142.16 | 139.74 | 141.94 | 8.073M |
| Oct 05, 2026 | 143.67 | 144.06 | 138.80 | 139.54 | 9.486M |
| Oct 02, 2026 | 143.77 | 144.35 | 142.73 | 144.30 | 9.662M |
| Oct 01, 2026 | 144.71 | 145.39 | 143.26 | 143.81 | 7.860M |
| Sep 30, 2026 | 148.94 | 149.27 | 145.26 | 145.31 | 10.23M |
| Sep 29, 2026 | 148.17 | 150.36 | 146.09 | 149.28 | 8.204M |
| Sep 28, 2026 | 147.65 | 149.19 | 146.28 | 148.69 | 7.701M |
| Sep 25, 2026 | 148.06 | 149.98 | 147.48 | 148.78 | 8.292M |
| Sep 24, 2026 | 148.16 | 151.46 | 147.90 | 147.98 | 10.31M |
| Sep 23, 2026 | 151.32 | 152.01 | 146.89 | 148.08 | 9.704M |
| Sep 22, 2026 | 148.69 | 153.57 | 148.04 | 150.91 | 11.17M |
| Sep 21, 2026 | 146.78 | 150.49 | 145.60 | 149.50 | 7.996M |
| Sep 18, 2026 | 147.08 | 147.84 | 145.74 | 146.87 | 31.16M |
| Sep 17, 2026 | 145.74 | 147.65 | 145.32 | 147.15 | 11.06M |
| Sep 16, 2026 | 143.96 | 144.97 | 143.50 | 144.91 | 7.231M |
| Sep 15, 2026 | 143.85 | 144.15 | 142.32 | 143.79 | 8.293M |
| Sep 14, 2026 | 146.42 | 147.09 | 144.10 | 144.85 | 7.414M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Johnson & Johnson | 255.56 |
| Eli Lilly & Co. | 1257.03 |
| Pfizer Inc. | 29.58 |
| Bristol Myers Squibb Co. | 59.75 |
| Viatris, Inc. | 18.66 |
Price Related Metrics
| PE Ratio | 116.66 |
| PS Ratio | 5.465 |
| Price to Book Value | 8.592 |
| Price to Free Cash Flow | 22.55 |
| Earnings Yield | 0.86% |
| Market Cap | 360.30B |
| Operating PE Ratio | 29.06 |
| Normalized PE Ratio | 48.25 |